- Home
- XBIT vs MRCC Comparison
XBIT vs MRCC Comparison
Compare XBIT & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- MRCC
- Stock Information
- Founded
- XBIT 2005
- MRCC 2011
- Country
- XBIT United States
- MRCC United States
- Employees
- XBIT N/A
- MRCC N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- MRCC Investment Managers
- Sector
- XBIT Health Care
- MRCC Finance
- Exchange
- XBIT Nasdaq
- MRCC Nasdaq
- Market Cap
- XBIT 194.5M
- MRCC 174.8M
- IPO Year
- XBIT 2015
- MRCC 2012
- Fundamental
- Price
- XBIT $3.25
- MRCC $8.59
- Analyst Decision
- XBIT
- MRCC Strong Buy
- Analyst Count
- XBIT 0
- MRCC 1
- Target Price
- XBIT N/A
- MRCC $9.00
- AVG Volume (30 Days)
- XBIT 52.0K
- MRCC 48.5K
- Earning Date
- XBIT 03-14-2025
- MRCC 03-10-2025
- Dividend Yield
- XBIT N/A
- MRCC 11.64%
- EPS Growth
- XBIT N/A
- MRCC 298.01
- EPS
- XBIT N/A
- MRCC 0.60
- Revenue
- XBIT N/A
- MRCC $62,007,000.00
- Revenue This Year
- XBIT N/A
- MRCC N/A
- Revenue Next Year
- XBIT N/A
- MRCC N/A
- P/E Ratio
- XBIT N/A
- MRCC $14.20
- Revenue Growth
- XBIT N/A
- MRCC N/A
- 52 Week Low
- XBIT $3.25
- MRCC $6.97
- 52 Week High
- XBIT $9.96
- MRCC $8.80
- Technical
- Relative Strength Index (RSI)
- XBIT 26.88
- MRCC 56.35
- Support Level
- XBIT $3.40
- MRCC $8.33
- Resistance Level
- XBIT $3.69
- MRCC $8.61
- Average True Range (ATR)
- XBIT 0.20
- MRCC 0.19
- MACD
- XBIT 0.05
- MRCC 0.01
- Stochastic Oscillator
- XBIT 3.85
- MRCC 67.44
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.